Professor Mark Dawson
Professor Mark Dawson is a Consultant Haematologist, Program Head of the Translational Haematology Program and Head of the Cancer Epigenetics Laboratory at Peter MacCallum Cancer Centre. He is internationally recognized as a leading clinician-scientist in the field of epigenetics and haematology.
Following his clinical training in Melbourne, Professor Dawson undertook a PhD at the University of Cambridge as a General Sir John Monash and Cambridge Commonwealth Trust Scholar. He was subsequently appointed as a Consultant Haematologist at Addenbrooke’s Hospital and a Wellcome Trust Beit Fellow at the University of Cambridge where he established his research focus investigating the regulation of normal and leukaemia stem cells.
Professor Dawson joined Peter MacCallum Cancer Centre in 2014 to continue his clinical and scientific research programs which aim to identify new therapies for the management of acute leukemia. He is the Senior Fellow for the Leukaemia Foundation Australia and a VESKI innovation fellow. He is also Professor of Medicine in the Sir Peter MacCallum Department of Oncology and the Centre for Cancer Research at the University of Melbourne.